Bruce Berkowitz
Fairholme Capital Management
Bruce Berkowitz DR Horton Inc stake
total: 120
Fairholme Capital Management DHI trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2022 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2022 Q3
According to 2026 Q2 report, Bruce Berkowitz doesn't hold any DR Horton Inc (DHI) shares. To date, the estimated cost basis is nearly $66.18 for "buy" trades and estimated average "sell" price is $66.18. Fairholme Capital Management first purchased DHI in 2022 Q2, initially acquiring 71,000 shares. Since the initial investment in DR Horton Inc (DHI), Fairholme Capital Management has made 1 more transaction.
When did Bruce Berkowitz sell DR Horton Inc (DHI)?
Bruce Berkowitz sold off the entire DR Horton Inc (DHI) position in 2022 Q3.
When did Bruce Berkowitz buy DR Horton Inc (DHI)?
Bruce Berkowitz first invested in DR Horton Inc (DHI) in 2022 Q2 at the reported quarter-end price of $66.18 per share.
What's the cost basis of Fairholme Capital Management's DHI stake?
The estimated cost basis for DR Horton Inc (DHI) stake is around $66.18 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $66.18
- Weighted AVG sell price:
- $66.18
Bruce Berkowitz's historical trades in DR Horton Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$66.18
|
|
-100% (-71,000)
|
-0.39%
|
|
2022 Q2
|
0.39%
|
71,000
|
$66.18
|
$4,699,000
|
new
|
+0.39%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.